Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $101,550 | 136 | 99.6% |
| Food and Beverage | $384.20 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Plasma Inc. | $101,550 | 136 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $200.11 | 2 | $0 (2018) |
| Grifols USA, LLC | $103.68 | 1 | $0 (2019) |
| Novo Nordisk Inc | $62.33 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.08 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60,235 | 83 | CSL Plasma Inc. ($60,235) |
| 2023 | $41,315 | 53 | CSL Plasma Inc. ($41,315) |
| 2019 | $103.68 | 1 | Grifols USA, LLC ($103.68) |
| 2018 | $106.81 | 1 | SANOFI-AVENTIS U.S. LLC ($106.81) |
| 2017 | $173.71 | 3 | SANOFI-AVENTIS U.S. LLC ($93.30) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $825.00 | General |
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $737.52 | General |
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $737.52 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $737.52 | General |
| 12/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $737.52 | General |
| 12/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $737.52 | General |
| 11/13/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $787.50 | General |
| 11/13/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $737.52 | General |
| 11/06/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $912.52 | General |
| 11/06/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 10/30/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $825.02 | General |
| 10/23/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $737.52 | General |
| 10/23/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $437.50 | General |
| 10/23/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| 10/09/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $737.52 | General |
| 10/09/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 10/02/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $912.52 | General |
| 10/02/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 09/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $962.50 | General |
| 09/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $825.02 | General |
| 09/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $825.02 | General |
| 09/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 09/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $825.02 | General |
| 09/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 377 | 413 | $551,882 | $35,534 |
| 2022 | 5 | 475 | 518 | $682,526 | $47,304 |
| 2021 | 7 | 472 | 500 | $626,577 | $44,420 |
| 2020 | 5 | 504 | 542 | $660,208 | $42,763 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 114 | 118 | $246,502 | $15,925 | 6.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 153 | 174 | $246,384 | $15,844 | 6.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 15 | $40,350 | $2,544 | 6.3% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 12 | 12 | $8,964 | $654.84 | 7.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 83 | 94 | $9,682 | $565.86 | 5.8% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 164 | 180 | $376,020 | $26,070 | 6.9% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 105 | 113 | $160,008 | $10,706 | 6.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 28 | 29 | $78,010 | $5,465 | 7.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 73 | 75 | $56,025 | $4,310 | 7.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 105 | 121 | $12,463 | $752.72 | 6.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 155 | 165 | $344,685 | $24,879 | 7.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 99 | 101 | $143,016 | $8,912 | 6.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 32 | 33 | $88,770 | $6,307 | 7.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 35 | 37 | $27,639 | $1,937 | 7.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 15 | $7,523 | $1,443 | 19.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 123 | 132 | $13,596 | $780.45 | 5.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 17 | $1,348 | $161.10 | 12.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 156 | 166 | $346,774 | $21,800 | 6.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 94 | 103 | $145,848 | $9,350 | 6.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 33 | 33 | $88,770 | $6,388 | 7.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 76 | 84 | $62,748 | $4,234 | 6.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 145 | 156 | $16,068 | $991.31 | 6.2% |
About Dr. John Wang, DO
Dr. John Wang, DO is a Family Medicine healthcare provider based in Springfield, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1558511519.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Wang, DO has received a total of $101,935 in payments from pharmaceutical and medical device companies, with $60,235 received in 2024. These payments were reported across 141 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($101,550).
As a Medicare-enrolled provider, Wang has provided services to 1,828 Medicare beneficiaries, totaling 1,973 services with total Medicare billing of $170,021. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Springfield, IL
- Active Since 09/26/2008
- Last Updated 11/16/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1558511519
Products in Payments
- SOTAGLIFLOZIN (Drug) $106.81
- HyperRAB SD (Biological) $103.68
- SOLIQUA (Drug) $93.30
- Xultophy 100/3.6 (Drug) $62.33
- STIOLTO (Drug) $18.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Springfield
Stephen Adams, Md, MD
Family Medicine — Payments: $582,513
Dennis Morrison, Do, DO
Family Medicine — Payments: $404,412
Dr. Roger Cady, Md, MD
Family Medicine — Payments: $175,721
Dr. Ali Bajwa, M.d, M.D
Family Medicine — Payments: $169,373
Dr. Christopher Davis, Do, DO
Family Medicine — Payments: $124,570
Dr. William Warning, Md, MD
Family Medicine — Payments: $60,578